Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study
NCT ID: NCT01378065
Last Updated: 2020-05-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
31 participants
OBSERVATIONAL
2011-06-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
NCT02680145
Prospective Analysis of Restorelle in the Treatment of Uterine Prolapse
NCT02921451
Prospective Observational Prolapse Study
NCT04701047
Clinical Outcomes and Urodynamic Effects After Vaginal Tailored Mesh Surgery for Pelvic Organ Prolapse
NCT02178735
GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ Prolapse
NCT00521066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Restorelle Direct Fix A&P
Restorelle Direct Fix A\&P is a permanently implantable synthetic mesh for reconstruction of the pelvic floor secondary to the prolapse or protrusion of the pelvic organs into or out of the vaginal canal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide written informed consent
* Diagnosed with clinically significant pelvic organ prolapse of Stage 2 or higher as determined by Pelvic Organ Prolapse Quantification System (POP-Q) requiring surgical intervention in the anterior and/or posterior compartment
* Willing and able to complete all follow-up visits and procedures indicated in the protocol
Exclusion Criteria
* Confirmed Stage 2 or higher prolapse as determined by POP-Q for a compartment that is not being repaired in the same procedure
* Previous pelvic organ prolapse repair using synthetic grafts
* Patients requiring a total hysterectomy (i.e. removal of the cervix) at the time of vaginal reconstruction
* Patients requiring a procedure for fecal incontinence (i.e.) anal sphincteroplasty) at the time of vaginal reconstruction
* Pregnant or a desire to become pregnant
* Previous radiation or other treatments for cancer in the pelvic area
* Immunosuppression and/or current systemic steroid user
* On any anticoagulation therapy at the time of implant or with bleeding diathesis
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry Jarnagin, MD
Role: PRINCIPAL_INVESTIGATOR
Center for Pelvic Health, Franklin, TN, United States
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MedStar Health Research Institute at Baltimore
Baltimore, Maryland, United States
Female Pelvic Medicine & Urogynecology Institute of MI
Grand Rapids, Michigan, United States
Central Missouri Women's Healthcare
Marshall, Missouri, United States
Center for Pelvic Health
Franklin, Tennessee, United States
The Group for Women
Norfolk, Virginia, United States
Integrity Medical Research, LLC
Mountlake Terrace, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
US011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.